These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 38428068)
1. AGCM-22, a novel cetuximab-based EGFR-targeting antibody-drug-conjugate with highly selective anti-glioblastoma efficacy. Li D; Sun X; Li Y; Shang C; Dong Y; Zhao R; Zhang H; Wang Z; Fan S; Ma C; Li X Bioorg Med Chem; 2024 Mar; 102():117657. PubMed ID: 38428068 [TBL] [Abstract][Full Text] [Related]
2. Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate. Phillips AC; Boghaert ER; Vaidya KS; Falls HD; Mitten MJ; DeVries PJ; Benatuil L; Hsieh CM; Meulbroek JA; Panchal SC; Buchanan FG; Durbin KR; Voorbach MJ; Reuter DR; Mudd SR; Loberg LI; Ralston SL; Cao D; Gan HK; Scott AM; Reilly EB Mol Cancer Ther; 2018 Apr; 17(4):795-805. PubMed ID: 29483208 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer Therapy. Glatt DM; Beckford Vera DR; Prabhu SS; Mumper RJ; Luft JC; Benhabbour SR; Parrott MC Mol Pharm; 2018 Nov; 15(11):5089-5102. PubMed ID: 30226780 [TBL] [Abstract][Full Text] [Related]
4. Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload. Wang Y; Fan S; Zhong W; Zhou X; Li S Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841157 [TBL] [Abstract][Full Text] [Related]
5. An EGFR-targeting antibody-drug conjugate LR004-VC-MMAE: potential in esophageal squamous cell carcinoma and other malignancies. Hu XY; Wang R; Jin J; Liu XJ; Cui AL; Sun LQ; Li YP; Li Y; Wang YC; Zhen YS; Miao QF; Li ZR Mol Oncol; 2019 Feb; 13(2):246-263. PubMed ID: 30372581 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and targeted chemotherapy of SCT200-linker-monomethyl auristatin E conjugates. Hu X; Jiang H; Bai W; Liu X; Miao Q; Wang L; Jin J; Cui A; Liu R; Li Z Eur J Med Chem; 2021 Apr; 216():113297. PubMed ID: 33677351 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Antibody-Drug Conjugate (ADC): Results of In Vitro and In Vivo Studies. Kang X; Zhou L; Jian YM; Lan SA; Xu F Med Sci Monit; 2018 Mar; 24():1408-1416. PubMed ID: 29515096 [TBL] [Abstract][Full Text] [Related]
8. Targeting Multiple EGFR-expressing Tumors with a Highly Potent Tumor-selective Antibody-Drug Conjugate. Anderson MG; Falls HD; Mitten MJ; Oleksijew A; Vaidya KS; Boghaert ER; Gao W; Palma JP; Cao D; Chia PL; John T; Gan HK; Scott AM; Reilly EB Mol Cancer Ther; 2020 Oct; 19(10):2117-2125. PubMed ID: 32847977 [TBL] [Abstract][Full Text] [Related]
9. Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy. Li Z; Wang M; Yao X; Luo W; Qu Y; Yu D; Li X; Fang J; Huang C Target Oncol; 2019 Feb; 14(1):93-105. PubMed ID: 30635821 [TBL] [Abstract][Full Text] [Related]
12. Exploring the Sensitivity of Antibody-Drug Conjugate Efficacy to the Selection of Payload, Antibody, and Cell line. Rao M; Murali S; Amores D; Yu F; Tsourkas A Bioconjug Chem; 2024 Jan; 35(1):115-124. PubMed ID: 38173338 [TBL] [Abstract][Full Text] [Related]
13. A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs. Yu SF; Zheng B; Go M; Lau J; Spencer S; Raab H; Soriano R; Jhunjhunwala S; Cohen R; Caruso M; Polakis P; Flygare J; Polson AG Clin Cancer Res; 2015 Jul; 21(14):3298-306. PubMed ID: 25840969 [TBL] [Abstract][Full Text] [Related]
15. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy. Ye Z; Zhang Y; Liu Y; Liu Y; Tu J; Shen Y Int J Nanomedicine; 2021; 16():2443-2459. PubMed ID: 33814909 [TBL] [Abstract][Full Text] [Related]
16. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer. Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870 [TBL] [Abstract][Full Text] [Related]
17. Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo. Eller JL; Longo SL; Kyle MM; Bassano D; Hicklin DJ; Canute GW Neurosurgery; 2005; 56(1):155-62; discussion 162. PubMed ID: 15617598 [TBL] [Abstract][Full Text] [Related]
18. Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Abdollahpour-Alitappeh M; Lotfinia M; Bagheri N; Sineh Sepehr K; Habibi-Anbouhi M; Kobarfard F; Balalaie S; Foroumadi A; Abbaszadeh-Goudarzi G; Abbaszadeh-Goudarzi K; Abolhassani M J Cell Physiol; 2019 Mar; 234(3):2693-2704. PubMed ID: 30246298 [TBL] [Abstract][Full Text] [Related]
19. Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates. Caculitan NG; Dela Cruz Chuh J; Ma Y; Zhang D; Kozak KR; Liu Y; Pillow TH; Sadowsky J; Cheung TK; Phung Q; Haley B; Lee BC; Akita RW; Sliwkowski MX; Polson AG Cancer Res; 2017 Dec; 77(24):7027-7037. PubMed ID: 29046337 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of a 5T4 targeting antibody drug conjugate with a novel payload derived from MMAF via C-Lock linker. Shi B; Wu M; Li Z; Xie Z; Wei X; Fan J; Xu Y; Ding D; Akash SH; Chen S; Cao S Cancer Med; 2019 Apr; 8(4):1793-1805. PubMed ID: 30843650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]